Exploring chromosomal structural heterogeneity across multiple cell lines
Abstract
Using computer simulations, we generate cell-specific 3D chromosomal structures and compare them to recently published chromatin structures obtained through microscopy. We demonstrate using machine learning and polymer physics simulations that epigenetic information can be used to predict the structural ensembles of multiple human cell lines. Theory predicts that chromosome structures are fluid and can only be described by an ensemble, which is consistent with the observation that chromosomes exhibit no unique fold. Nevertheless, our analysis of both structures from simulation and microscopy reveals that short segments of chromatin make two-state transitions between closed conformations and open dumbbell conformations. Finally, we study the conformational changes associated with the switching of genomic compartments observed in human cell lines. The formation of genomic compartments resembles hydrophobic collapse in protein folding, with the aggregation of denser and predominantly inactive chromatin driving the positioning of active chromatin toward the surface of individual chromosomal territories.
Data availability
All of the simulated chromosome structures have been deposited in the Nucleome Data Bank (https://ndb.rice.edu/Data).
-
Cheng_etal_H1-hESC_2020Nucleome Data Bank, Cheng_etal_H1-hESC_2020.
-
Cheng_etal_HUVEC_2020Nucleome Data Bank, Cheng_etal_HUVEC_2020.
-
Cheng_etal_HMEC_2020Nucleome Data Bank, Cheng_etal_HMEC_2020.
-
Cheng_etal_Hela-S3_2020Nucleome Data Bank, Cheng_etal_Hela-S3_2020.
-
Cheng_etal_IMR90_2020Nucleome Data Bank, Cheng_etal_IMR90_2020.
-
Cheng_etal_K562_2020Nucleome Data Bank, Cheng_etal_K562_2020.
-
IMR90_chr21-18-20Mb.csvIMR90_chr21-18-20Mb.csv.
-
IMR90_chr21-28-30Mb.csvIMR90_chr21-28-30Mb.csv.
-
K562_chr21-28-30Mb.csvK562_chr21-28-30Mb.csv.
Article and author information
Author details
Funding
National Science Foundation (PHY-1427654)
- Ryan R Cheng
- Vinicius Contessoto
- Erez Lieberman-Aiden
- Peter G Wolynes
- Michele Di Pierro
- Jose N Onuchic
NHGRI Center for Excellence for Genomic Sciences (HG006193)
- Erez Lieberman-Aiden
Welch Foundation (Q-1866)
- Erez Lieberman-Aiden
Cancer Prevention and Research Institute of Texas (R1304)
- Erez Lieberman-Aiden
NIH Office of the Director (U01HL130010)
- Erez Lieberman-Aiden
NIH Office of the Director (UM1HG009375)
- Erez Lieberman-Aiden
NVIDIA Research Center Award
- Erez Lieberman-Aiden
IBM University Challenge Award
- Erez Lieberman-Aiden
Google Research Award
- Erez Lieberman-Aiden
McNair Medical Institute Scholar
- Erez Lieberman-Aiden
President's Early Career in Science and Engineering
- Erez Lieberman-Aiden
National Science Foundation (CHE-1614101)
- Jose N Onuchic
Welch Foundation (C-1792)
- Jose N Onuchic
Cancer Prevention and Research Institute of Texas
- Jose N Onuchic
Welch Foundation
- Vinicius Contessoto
Sao Paulo Research Foundation and Higher Education Personnel (2016/13998-8)
- Vinicius Contessoto
Higher Education Personnel Improvement Coordination (2017/09662-7)
- Vinicius Contessoto
D. R. Bullard-Welch Chair at Rice University (Grant C-0016)
- Peter G Wolynes
NIH Office of the Director (1DP2OD008540-01)
- Erez Lieberman-Aiden
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Yibing Shan, DE Shaw Research, United States
Version history
- Received: June 22, 2020
- Accepted: October 8, 2020
- Accepted Manuscript published: October 13, 2020 (version 1)
- Version of Record published: October 28, 2020 (version 2)
Copyright
© 2020, Cheng et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 2,180
- views
-
- 350
- downloads
-
- 43
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Chromosomes and Gene Expression
Eukaryotic chromatin is organized into functional domains, that are characterized by distinct proteomic compositions and specific nuclear positions. In contrast to cellular organelles surrounded by lipid membranes, the composition of distinct chromatin domains is rather ill described and highly dynamic. To gain molecular insight into these domains and explore their composition, we developed an antibody-based proximity-biotinylation method targeting the RNA and proteins constituents. The method that we termed Antibody-Mediated-Proximity-Labelling-coupled to Mass Spectrometry (AMPL-MS) does not require the expression of fusion proteins and therefore constitutes a versatile and very sensitive method to characterize the composition of chromatin domains based on specific signature proteins or histone modifications. To demonstrate the utility of our approach we used AMPL-MS to characterize the molecular features of the chromocenter as well as the chromosome territory containing the hyperactive X-chromosome in Drosophila. This analysis identified a number of known RNA binding proteins in proximity of the hyperactive X and the centromere, supporting the accuracy of our method. In addition, it enabled us to characterize the role of RNA in the formation of these nuclear bodies. Furthermore, our method identified a new set of RNA molecules associated with the Drosophila centromere. Characterization of these novel molecules suggested the formation of R-loops in centromeres, which we validated using a novel probe for R-loops in Drosophila. Taken together, AMPL-MS improves the selectivity and specificity of proximity ligation allowing for novel discoveries of weak protein-RNA interactions in biologically diverse domains.
-
- Cancer Biology
- Chromosomes and Gene Expression
The chromatin-associated protein WD Repeat Domain 5 (WDR5) is a promising target for cancer drug discovery, with most efforts blocking an arginine-binding cavity on the protein called the ‘WIN’ site that tethers WDR5 to chromatin. WIN site inhibitors (WINi) are active against multiple cancer cell types in vitro, the most notable of which are those derived from MLL-rearranged (MLLr) leukemias. Peptidomimetic WINi were originally proposed to inhibit MLLr cells via dysregulation of genes connected to hematopoietic stem cell expansion. Our discovery and interrogation of small-molecule WINi, however, revealed that they act in MLLr cell lines to suppress ribosome protein gene (RPG) transcription, induce nucleolar stress, and activate p53. Because there is no precedent for an anticancer strategy that specifically targets RPG expression, we took an integrated multi-omics approach to further interrogate the mechanism of action of WINi in human MLLr cancer cells. We show that WINi induce depletion of the stock of ribosomes, accompanied by a broad yet modest translational choke and changes in alternative mRNA splicing that inactivate the p53 antagonist MDM4. We also show that WINi are synergistic with agents including venetoclax and BET-bromodomain inhibitors. Together, these studies reinforce the concept that WINi are a novel type of ribosome-directed anticancer therapy and provide a resource to support their clinical implementation in MLLr leukemias and other malignancies.